If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Samanta Sarti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 54 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

  • Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

    Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

    Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

    Research output: Contribution to journalArticle

    Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?

    Palleschi, M., Maltoni, R., Sarti, S., Melegari, E., Bravaccini, S. & Rocca, A., Jan 1 2019, (Accepted/In press) In : Breast Journal.

    Research output: Contribution to journalArticle

  • Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

    Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, p. 1-9 9 p., 207.

    Research output: Contribution to journalArticle